Company: TXG
Filing Date: 2025-05-09
Form Type: 10-Q
Source: 0001770787-25-000032
Chunk: 162

Company: 10x Genomics, Inc.
Filing Date: 2025-05-09
Form: 10-Q
Item: Part I, Item 4
Chunk 162
---
changes in general market conditions and other factors, including factors unrelated to our operating performance or the performance of our competitors;

•the effects of inflation on us or our customers, manufacturers and suppliers, including increases in the cost of labor and materials, including as a result of tariffs imposed by the United States which are currently, or in the future, under consideration, proposed or enacted;

•excess capacity expenses and inventory write-downs; 

•changes in volume and product mix, particularly from products with lower gross margins than other products that we sell, or changes in costs related to our instruments and consumables, including products which incur royalty payment obligations at higher rates than other products we sell;

•the success of our recently introduced and recently announced products and new versions of existing products, and our ability to generate revenue for such products, and the introduction of new products or product enhancements by us or others in our industry including the timing of such introductions;

•disruptions in customers’ on-going experiments or interruptions in the ability of our customers to complete research projects;

•investment decisions we make with respect to the allocation of our resources, including regarding product development or to support our commercial organization;

•risks related to our business and demand for our products in China and elsewhere in the Asia-Pacific region, including competition or other factors;

•differences in purchasing patterns across our customer base or across our two portfolios and variances in consumables spending for each of our portfolios;

•higher than anticipated warranty costs;

•the timing and amount of expenditures that we may incur to acquire, develop or commercialize additional products and technologies or for other purposes;

26

•the timing and amount of expenditures (including success fees) related to litigation, as well as the outcomes of and related rulings in the litigation and administrative proceedings which may vary substantially from quarter to quarter;

•the outcome of any current or future litigation or governmental investigations involving us or other third parties;

•our ability and the ability of our partners to successfully manufacture our instruments and consumables in necessary quantities at necessary quality, including due to the impacts of supply chain disruptions, logistics, shipping and other distribution disruptions and labor shortages;

•shortages, delays, production problems, distribution and quality issues with the materials we purchase for manufacturing, which could impact our ability to manufacture and ship our instruments, consumables and related components;

•our inability or the inability of our customers to source our products or necessary equipment, components and materials used in our products or in conjunction with our products, including shortages of consumables or other components and materials